Given the unexpected couple of years we have had as a result of the Covid-19 pandemic, the drug discovery sector is no doubt looking forward to an in-person event at last. ELRIG UK’s Drug Discovery 2021 will take place at the ACC, Liverpool, UK on 19-20 October.
DDW has teamed up with ELRIG UK to produce an exclusive supplement containing insight from experts across the industry who are looking forward re-connecting.
The ELRIG UK supplement covers the themes of the event: Re-imagine, Re-invent and Re-connect. Highlights include interviews with Rob Howes, Director of AstraZeneca’s Cambridge Covid-19 Testing Centre and UK Director of Structural and Biophysical Science at GSK, Chun Wa Chung who discusses the power of an inclusive drug discovery community. Meanwhile Guido Lanza, VP of Integrated Research at Valo Health, reveals how Valo is re-inventing and innovating to overcome the challenges of drug discovery and development.
What to expect at ELRIG UK’s Drug Discovery 2021:
The ELRIG UK App
Download the free ELRIG UK app and access information, schedules and more, straight from your phone or iPad. The app will enable you to:
- View lecture, speaker profiles and poster abstracts
- View exhibitor video presentations
- Rate lectures and participate in polls
- View the exhibitor interactive floor plan
- In-messaging to speakers, delegates and exhibitors
- Organise your day with your own favourites list
- Share your profile as vCard and QR Code and scan exhibitor QR code information tags.
One of the themes of Drug Discovery 2021 is re-connect, and while ELRIG UK, offers business and career opportunities it is also a chance to socialise with like-minded industry professionals. So, not only does the ELRIG app provide you with an organisational tool, it also makes contacting other delegates and speakers easy through opt-in directories and integration with LinkedIn, Twitter and Facebook.
To download the app, visit the app store appropriate to your tablet or smart phone.
Drug Discovery 2021 To Host Slas’s Innovation AveNEW
The ELRIG Drug Discovery 2021 programme includes hosting the Society for Laboratory Automation and Screening (SLAS)’s Innovation AveNEW, which will showcase emerging innovations and companies.
Vicki Loise, CEO of SLAS, said: “The companies selected for our Innovation AveNEW are given the opportunity to raise awareness of their new company, product or service to a global audience. At SLAS, we are very pleased to partner with ELRIG UK, and we are confident that the inclusion of our Innovation AveNEW in this year’s Drug Discovery programme will complement its mission to provide freely accessibly scientific content, promotion and networking opportunities.”
SLAS has been accepting applications from startup and emerging technology companies for ten spots at the exhibition.
Companies selected for THE SLAS Innovation AveNEW are given the opportunity to promote of their new company, product or service. This specially designated area of the exhibition will connect attendees to purchasing influencers and decision-makers from around the world — at no cost.
Drug Discovery 2021 promises to provide a platform for the whole drug discovery community to meet, where members of ELRIG UK’s community may:
- Re-connect with colleagues, as well as hear stories from scientists who have been responsible for combatting Covid-19 in the session tracks on infection and diagnostics.
- Re-invent the process of drug discovery, by building diverse partnerships with even greater emphasis on efficiency, automation, and remote operation in our two session tracks of screening and chemistry.
- Re-imagine and create a new vision for drug discovery, with insights from our innovation and disruptive strategies tracks.
Part of the mission of ELRIG UK is encourage and foster new technologies, from innovative companies.
The Innovation Zone gives up-and-coming companies, with new technologies or services, who cannot afford a full stand, access to a major event and critical exposure to the market.
Early Career Professionals
ELRIG UK recognises and celebrates Early Career Professionals (ECPs) that make a clear impact on the wider scientific community. This may be achieved in a variety of ways: Through delivery of impactful science, contributing to early, pre-clinical drug discovery by science or technology development work via leadership or facilitation of collaborations in the drug-discovery space, or through other philanthropic and volunteering contributions.
In order to celebrate ECPs and their role in the industry, Drug Discovery 2021 has a number of opportunities and activities planned throughout the conference for this group, from networking workshops to CV writing.